Clinical Trial Update: Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen® [NA]

View source ↗

Summary

This clinical trial, currently recruiting, compares radiographic fusion rate and clinical outcomes of ALIF and XLIF procedures using either recombinant human bo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Spondylolisthesis
• Spondylosis

Drugs mentioned

• ViviGen
• rhBMP-2 (Infuse) (bone morphogenetic protein-2)

Snippet

Sponsor: Lindenhofgruppe AG | Conditions: Spondylosis, Spondylolisthesis | NA | Status: RECRUITING